Meeting
2019 Genitourinary Cancers Symposium
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
Authors
Taavi Neklesa
Arvinas, New Haven, CT
Taavi Neklesa , Lawrence B Snyder , Ryan R Willard , Nicholas Vitale , Jennifer Pizzano , Deborah A Gordon , Mark Bookbinder , Jennifer Macaluso , Hanqing Dong , Caterina Ferraro , Gan Wang , Jing Wang , Craig M Crews , John Houston , Andrew P Crew , Ian Taylor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 259)
DOI
10.1200/JCO.2019.37.7_suppl.259
Abstract #
259
Poster Bd #
L16
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
An oral androgen receptor PROTAC degrader for prostate cancer.
First Author: Taavi Neklesa
Poster
2017 Genitourinary Cancers Symposium
An oral androgen receptor PROTAC degrader for prostate cancer.
First Author: Taavi K Neklesa
Poster
2015 Genitourinary Cancers Symposium
Effect of lipid nanoparticle siRNA delivery systems on silencing clusterin and progression in enzalutamide resistant prostate cancer in vivo.
First Author: Yoshiaki Yamamoto
Poster
2019 Genitourinary Cancers Symposium
Measurement science of the androgen receptor splice variant-7 protein in primary and castration-resistant prostate cancer tissue.
First Author: Adam Sharp